Drug name: PRIMA-1

Related CSCTT Targets

ALDH-high cells [ref.1]


Cas.no PubChem ID
5608-24-2 322968
Known Target
Cellular tumor antigen p53P04637
PRIMA-1, a novel low molecular weight compound, rescues the tumor-suppressing function of mutant p53 proteins and shows anti-tumor activity in vivo. P53 severs as a crucial tumor suppressor and mutant p53 is expressed at high levels in many tumors. PRIMA-1 is considered as a lead compound for the development of anticancer drugs targeting mutant p53.




  • [1] Targeting cancer stem cells with p53 modulators.
    Zhang, Z., L. Liu, R. Gomez-Casal, X. Wang, R. Hayashi, E. Appella, L. Kopelovich and A. B. DeLeo (2016). Oncotarget.. [ 27074569 ]

Back to top